Companies: 10,795·Total market cap: $144.5T
bioMérieux S.A.

bioMérieux S.A.

BMXXYOTCHealthcare● Active
$8.43
$-1.72(-16.95%)
Market Cap$9.9B
P/E Ratio
52W High$14.62
52W Low$7.9075
Overview

bioMérieux S.A. (BMXXY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BMXXY · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.70bmxxy eps ttm · bmxxy earnings per shareEarnings history
PE Ratio (TTM)12.0×bmxxy pe ratio ttm · bmxxy price to earningsPE Ratio deep dive
Revenue (TTM)$8.0Bbmxxy revenue ttm · bmxxy annual revenueFull revenue history
Dividend Yield1.35%does bmxxy pay dividends · bmxxy dividend yieldDividend history
Shares Outstanding1.18Bbmxxy shares outstanding · bmxxy floatShares outstanding history
Next EarningsTBAbmxxy earnings date · bmxxy next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$3.91B▼ 1.78% YoY
202320242025
biomérieux s.a. revenue · bmxxy revenue 2025
FY 2025Net Income$381.8M▼ 11.66% YoY
202320242025
biomérieux s.a. net income · bmxxy profit 2025
FY 2025EPS$0.32▼ 13.51% YoY
202320242025
bmxxy eps · biomérieux s.a. earnings per share 2025
TTM:Revenue: $8.03BNet Income: $827.8MEPS: $0.70View income statement →

Stock Performance

Full History
1D-16.95%
1W-7.36%
1M+6.04%
3M-42.06%
YTD-33.10%
1Y-34.90%
5Y-91.65%

About bioMérieux S.A.

CEOPierre Boulud
IPO DateJun 9, 2023
Employees14,147
CountryFR

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers …

what is biomérieux s.a. · bmxxy stock overview · biomérieux s.a. company profile · who is biomérieux s.a. ceo · bmxxy OTC · biomérieux s.a. headquarters · biomérieux s.a. business segments

About Stock Overview & Key Data

bioMérieux S.A. (BMXXY) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Jun 9, 2023. As of the latest trading session, BMXXY stock price is $8.43, with a market capitalization of $9.9B. The stock has returned -34.90% over the past 12 months and -33.10% year-to-date.

In fiscal year 2025, bioMérieux S.A. reported revenue of $3.9B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, bioMérieux S.A. (BMXXY) stock price is $8.43. The stock is traded on OTC under the ticker symbol BMXXY. The 52-week range is $7.91 – $14.62.

BMXXY stock priceBMXXY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice